TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 160 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q2 2016. The put-call ratio across all filers is 0.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $372,000 | +0.5% | 3,300 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $370,000 | -22.6% | 3,300 | -19.5% | 0.00% | 0.0% |
Q1 2017 | $478,000 | +16.3% | 4,100 | +5.1% | 0.00% | 0.0% |
Q4 2016 | $411,000 | -9.3% | 3,900 | -4.9% | 0.00% | 0.0% |
Q3 2016 | $453,000 | -18.1% | 4,100 | +7.9% | 0.00% | 0.0% |
Q2 2016 | $553,000 | +1.7% | 3,800 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $544,000 | -7.3% | 3,800 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $587,000 | – | 3,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ISZO CAPITAL LP | 1,104,068 | $104,886,000 | 77.66% |
Greywolf Capital Management LP | 472,135 | $46,694,000 | 10.17% |
Consonance Capital Management LP | 263,732 | $26,083,000 | 4.28% |
Moab Capital Partners | 83,132 | $8,222,000 | 3.77% |
Raging Capital Management, LLC | 190,151 | $18,806,000 | 3.45% |
Valentine Capital Asset Management, Inc. | 145,053 | $14,346,000 | 3.07% |
Assured Investment Management LLC | 1,353,342 | $133,846,000 | 1.21% |
Ativo Capital Management LLC | 22,828 | $2,258,000 | 0.99% |
Perceptive Advisors | 56,602 | $5,598,000 | 0.67% |
Jaffetilchin Investment Partners, LLC | 7,721 | $764,000 | 0.38% |